+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American Indapamide Market 2020-2026

  • PDF Icon

    Report

  • July 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 5145126
North American Indapamide Market Size, Share & Trends Analysis Report by product (1.25 mg and 2.5 mg), By Application (High Blood Pressure, Heart Failure, and Others), and Forecast 2020-2026.

North American indapamide market is estimated to grow significantly at a CAGR of around 0.3% during the forecast period. The market is mainly growing due to the rising prevalence of hypertension and CVD such as heart strokes, blood pressure, arrhythmias among others. According to the Heart & Stroke Foundation in Canada (2017), 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Further, the population is also more inclined to the risk of heart strokes. According to WHO, the incidence and prevalence rate of heart attacks are the highest in North America, which is responsible for 700,000 fatalities each year. Moreover, the rate of adoption of advanced techniques is the highest in North America which in turn supports the growth of the market in North America.

The North American indapamide market is segmented on the basis of product and application. Based on product, the market is bifurcated into 1.25 mg and 2.5 mg. Among these, the market for 1.25 mg medicine held the significant market share owing to the extensive application of the drug in treating high blood pressure or hypertension. Based on the application, the market is segmented into high blood pressure, heart failure, and others. The high blood pressure segment is projected to have significant share in the market. Growing incidence of hypertension is contributing to market growth as indapamide drugs are significantly used to treat hypertension while reducing the risk of developing serious heart conditions.

The companies which are contributing to the growth of the North American indapamide market include ANI Pharmaceuticals, Inc., Apotex Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., Mylan N.V., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Research Methodology

The market study of the North American indapamide market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The team collects facts and data related to the market from different geography to provide a better regional outlook.

In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for indapamide market players, potential entrants and pharmaceutical companies for the overall market and competitive analysis. The report provides an in-depth analysis on market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Indapamide Market Research and Analysis by Product
2. North American Indapamide Market Research and Analysis by Application

The Report Covers
  • Comprehensive research methodology of the North American indapamide market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American indapamide market.
  • Insights about market determinants which are stimulating the North American indapamide market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American Indapamide Market by Product
5.1.1. 1.25 MG
5.1.2. 2.5 MG
5.2. North American Indapamide Market by Application
5.2.1. High Blood Pressure
5.2.2. Heart Failure
5.2.3. Others
6. Regional Analysis
6.1. US
6.2. Canada
7. Company Profiles
7.1. ANI Pharmaceuticals, Inc.
7.2. Apotex Inc.
7.3. Glenmark Pharmaceuticals Ltd.
7.4. Krka Group
7.5. Mylan N.V.
7.6. Preferred Pharmaceuticals, Inc.
7.7. Sanis Health Inc.
7.8. Sanofi S.A.
7.9. Teva Pharmaceuticals Industries Ltd.
7.10. Servier Group
LIST OF TABLES
1. NORTH AMERICAN INDAPAMIDE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
2. NORTH AMERICAN INDAPAMIDE MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2019-2026 ($ MILLION)
3. NORTH AMERICAN INDAPAMIDE MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2019-2026 ($ MILLION)
LIST OF FIGURES
1. NORTH AMERICAN INDAPAMIDE MARKET SHARE BY COUNTRY, 2019 VS 2026 (%)
2. NORTH AMERICAN INDAPAMIDE MARKET SHARE BY PRODUCT, 2019 VS 2026 (%)
3. NORTH AMERICAN INDAPAMIDE MARKET SHARE BY APPLICATION, 2019 VS 2026 (%)
4. US INDAPAMIDE MARKET SIZE, 2019-2026 ($ MILLION)
5. CANADA INDAPAMIDE MARKET SIZE, 2019-2026 ($ MILLION)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • ANI Pharmaceuticals, Inc.
  • Apotex Inc.
  • Glenmark Pharmaceuticals Ltd.
  • Krka Group
  • Mylan N.V.
  • Preferred Pharmaceuticals, Inc.
  • Sanis Health Inc.
  • Sanofi S.A.
  • Teva Pharmaceuticals Industries Ltd.
  • Servier Group